This is not the most recent version of the article. View current version (6 OCT 2016)
Pharmacological interventions other than botulinum toxin for spasticity after stroke
Editorial Group: Cochrane Stroke Group
Published Online: 28 FEB 2013
Assessed as up-to-date: 10 NOV 2012
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Lindsay C, Pandyan AD. Pharmacological interventions other than botulinum toxin for spasticity after stroke (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 2. Art. No.: CD010362. DOI: 10.1002/14651858.CD010362.
- Publication Status: New
- Published Online: 28 FEB 2013
This is not the most recent version of the article. View current version (06 OCT 2016)
- Is stroke the most common cause of disability?. Journal of Stroke and Cerebrovascular Diseases 2004; Vol. 13, issue 4:171-7. , , .
- Stroke and neurodegenerative disorders. 3. Stroke: rehabilitation management. Archives of Physical Medicine and Rehabilitation 2004;85(3):S15-20, S34-40. , , , , .
- Spasticity as an adaptation to pyramidal tract injury. Advances in Neurology 1988;47:401. .
- Antispasticity drugs: mechanisms of action. Annals of Neurology 1985;17(2):107-16. .
- Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. , , .
- The human and economic burden of poststroke spasticity and muscle overactivity. Journal of Clinical Outcomes Management 2011;18(1):34-44. .
- A clinical overview of treatment decisions in the management of spasticity. Muscle and Nerve Supplement 1997;20(S6):S14-S20. , , .
- Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle & Nerve Supplement. Wiley, 1997; Vol. 20, issue S6:S92-120. , , , , .
- Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58. , .
- Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. , , .
- Baclofen reduces post-synaptic potentials of rat cortical neurones by an action other than its hyperpolarizing action. Journal of Physiology 1987;384:539-69. , , .
- Comparison of phenol and alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle for treatment of spastic foot after stroke: a randomized controlled pilot study. European Journal of Physical and Rehabilitation Medicine 2010;46(1):5-10. , , , .
RevMan 2012 [Computer program]
- The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Royal College of Physicians 2009
- Royal College of Physicians, British Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, Association of Chartered Physiotherapists Interested in Neurology. Spasticity In Adults: Management Using Botulinum Toxin. National Guidelines. London: RCP, 2009.
- Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: international consensus statement. European Journal of Neurology 2010;17:74-93. , , , , .
van Tulder 1997
- Tolperisone. Journal of the Association of Physicians of India 2010;58:127-8. .
- The effect of baclofen and diazepam on motor skill acquisition in healthy subjects. Experimental Brain Research 2011; Vol. 213, issue 4:465-74. , , , .